Sarepta Therapeutics (SRPT) PT Lowered to $75 at Needham & Company; 'FY17 Guidance Significantly Below Expectations'
Go back to Sarepta Therapeutics (SRPT) PT Lowered to $75 at Needham & Company; 'FY17 Guidance Significantly Below Expectations'| SAREPTA THERAP (NASDAQ: SRPT) | Delayed: 22.50 -0.49 (2.13%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $22.99 | 52 Week High | $63.73 | |||
| Open | $22.58 | 52 Week Low | $8.00 | |||
| Day High | $22.65 | P/E | N/A | |||
| Day Low | $21.98 | EPS | $-5.69 | |||
| Volume | 2,955,534 | |||||

